Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-18-002521
Filing Date
2018-08-31
Accepted
2018-08-31 16:19:29
Documents
1
Period of Report
2018-08-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form311577002_08312018.html 3  
1 OWNERSHIP DOCUMENT form311577002_08312018.xml 3 1541
  Complete submission text file 0000921895-18-002521.txt   3156
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Issuer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PLX PHARMA,INC.8285 EL RIO STREET SUITE 210 HOUSTON TX 77054
Business Address
Deliargyris Efthymios (Reporting) CIK: 0001751617 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36351 | Film No.: 181050354